The mechanistic basis of arsenicosis: Pathogenesis of skin cancer

Cancer Letters

Volumn 354, Issue 2, 2014, Pages 211-219

  Hunt, Katherine M ^a   Srivastava, Ritesh K ^b   Elmets, Craig A ^b   Athar, Mohammad ^b  

^a UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Arsenic; Arsenicosis; Carcinogenesis; Oxidative stress; Pathogenesis

Indexed keywords

GLUTATHIONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; GROUND WATER;

APOPTOSIS; ARSENIC POISONING; CELL SURVIVAL; DISEASE ASSOCIATION; DISEASE MODEL; DNA DAMAGE; DOWN REGULATION; GENOMIC INSTABILITY; GENOTOXICITY; HOMEOSTASIS; HUMAN; IMMUNOPATHOLOGY; NONHUMAN; OXIDATION REDUCTION POTENTIAL; OXIDATIVE STRESS; PROTEIN EXPRESSION; SHORT SURVEY; SIGNAL TRANSDUCTION; SKIN CANCER; SKIN CARCINOGENESIS; UPREGULATION; ANIMAL; CHEMICALLY INDUCED; ENVIRONMENTAL EXPOSURE; PATHOLOGY; SKIN TUMOR;

ANIMALS; ARSENIC POISONING; ENVIRONMENTAL EXPOSURE; GROUNDWATER; HUMANS; SKIN NEOPLASMS;

EID: 84907984929     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2014.08.016     Document Type: Review

References (96)

1. Kumagai Y., Sumi D. Arsenic: signal transduction, transcription factor, and biotransformation involved in cellular response and toxicity. Annu. Rev. Pharmacol. Toxicol 2007, 47:243-262.
2. Martinez V.D., Vucic E.A., Becker-Santos D.D., Gil L., Lam W.L. Arsenic exposure and the induction of human cancers. J Toxicol 2011, 2011:431287.
3. Yu H.S., Liao W.T., Chai C.Y. Arsenic carcinogenesis in the skin. J. Biomed. Sci 2006, 13(5):657-666. Epub 2006 Jun 29.
4. IARC A Review of Human Carcinogens: Arsenic, Metals, Fibres, and Dusts 2012, Vol. 100C. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, International Agency for Research on Cancer, World Health Organization, Lyon, France.
5. Surdu S., Fitzgerald E.F., Bloom M.S., Boscoe F.P., Carpenter D.O., Haase R.F., et al. Occupational exposure to arsenic and risk of nonmelanoma skin cancer in a multinational European study. Int. J. Cancer 2013, 133(9):2182-2191.
6. WHO Arsenic in Drinking-Water. Background Document for Development of WHO Guidelines for Drinking-Water Quality 2011, World Health Organization, Geneva, Switzerland.
7. Naujokas M.F., Anderson B., Ahsan H., Aposhian H.V., Graziano J.H., Thompson C., et al. The broad scope of health effects from chronic arsenic exposure: update on a worldwide public health problem. Environ. Health Perspect 2013, 121(3):295-302.
8. Wong S.S., Tan K.C., Goh C.L. Cutaneous manifestations of chronic arsenicism: review of seventeen cases. J. Am. Acad. Dermatol 1998, 38(2 Pt 1):179-185.
9. Flanagan S.V., Johnston R.B., Zheng Y. Arsenic in tube well water in Bangladesh: health and economic impacts and implications for arsenic mitigation. Bull. World Health Organ 2012, 90(11):839-846.
10. Rodríguez-Lado L., Sun G., Berg M., Zhang Q., Xue H., Zheng Q., et al. Groundwater arsenic contamination throughout China. Science 2013, 341(6148):866-868.
11. Dangleben N.L., Skibola C.F., Smith M.T. Arsenic immunotoxicity: a review. Environ. Health 2013, 12(1):73.
12. Biswas J., Sinha D., Mukherjee S., Roy S., Siddiqi M., Roy M. Curcumin protects DNA damage in a chronically arsenic-exposed population of West Bengal. Hum. Exp. Toxicol 2010, 29(6):513-524. Epub 2010 Jan 7. 10.1177/0960327109359020.
13. Wasserman G.A., Liu X., Loiacono N.J., Kline J., Factor-Litvak P., van Geen A., et al. A cross-sectional study of well water arsenic and child IQ in Maine schoolchildren. Environ. Health 2014, 13(1):23.
14. Yu G., Sun D., Zheng Y. Health effects of exposure to natural arsenic in groundwater and coal in China: an overview of occurrence. Environ. Health Perspect 2007, 115(4):636-642. Epub 2007 Jan 9.
15. Parvez F., Wasserman G.A., Factor-Litvak P., Liu X., Slavkovich V., Siddique A.B., et al. Arsenic exposure and motor function among children in Bangladesh. Environ. Health Perspect 2011, 119(11):1665-1670.
16. Syed E.H., Poudel K.C., Sakisaka K., Yasuoka J., Ahsan H., Jimba M. Quality of life and mental health status of arsenic-affected patients in a Bangladeshi population. J. Health Popul. Nutr 2012, 30(3):262-269.
17. Parvez F., Chen Y., Yunus M., Olopade C., Segers S., Slavkovich V., et al. Arsenic exposure and impaired lung function. Findings from a large population-based prospective cohort study. Am. J. Respir. Crit. Care Med 2013, 188(7):813-819.
18. Benbrahim-Tallaa L., Waalkes M.P. Inorganic arsenic and human prostate cancer. Environ. Health Perspect 2008, 116(2):158-164.
19. National Toxicology Program Report on Carcinogens 2011, Research Triangle Park, NC:NTP, (accessed 14.04.28). http://ntp.niehs.nih.gov/ntp/roc/twelfth/profiles/arsenic.pdf, 12th ed.
20. Chen Y., Wu F., Graziano J.H., Parvez F., Liu M., Paul R.R., et al. Arsenic exposure from drinking water, arsenic methylation capacity, and carotid intima-media thickness in Bangladesh. Am. J. Epidemiol 2013, 178(3):372-381.
21. Chen Y., Graziano J.H., Parvez F., Liu M., Slavkovich V., Kalra T., et al. Arsenic exposure from drinking water and mortality from cardiovascular disease in Bangladesh: prospective cohort study. BMJ 2011, 342:d2431.
22. Wu F., Jasmine F., Kibriya M.G., Liu M., Cheng X., Parvez F., et al. Interaction between arsenic exposure from drinking water and genetic susceptibility in carotid intima-media thickness in Bangladesh. Toxicol. Appl. Pharmacol 2014, 276(3):195-203.
23. Maull E.A., Ahsan H., Edwards J., Longnecker M.P., Navas-Acien A., Pi J., et al. Evaluation of the association between arsenic and diabetes: a National Toxicology Program workshop review. Environ. Health Perspect 2012, 120(12):1658-1670.
24. Li C., Xu J., Li F., Chaudhary S.C., Weng Z., Wen J., et al. Unfolded protein response signaling and MAP kinase pathways underlie pathogenesis of arsenic-induced cutaneous inflammation. Cancer Prev. Res. (Phila.) 2011, 4(12):2101-2109.
25. Melkonian S., Argos M., Chen Y., Parvez F., Pierce B., Ahmed A., et al. Intakes of several nutrients are associated with incidence of arsenic-related keratotic skin lesions in Bangladesh. J. Nutr 2012, 142(12):2128-2134.
26. Ghosh S.K., Bandyopadhyay D., Bandyopadhyay S.K., Debbarma K. Cutaneous malignant and premalignant conditions caused by chronic arsenicosis from contaminated ground water consumption: a profile of patients from eastern India. Skinmed 2013, 11(4):211-216.
27. Banerjee N., Paul S., Sau T.J., Das J.K., Bandyopadhyay A., Banerjee S., et al. Epigenetic modifications of DAPK and p16 genes contribute to arsenic-induced skin lesions and nondermatological health effects. Toxicol. Sci 2013, 135(2):300-308. Epub 2013 Jul 20. 10.1093/toxsci/kft163.
28. Ahsan H., Steinmaus C. Invited commentary: use of arsenical skin lesions to predict risk of internal cancer: implications for prevention and future research. Am. J. Epidemiol 2013, 177(3):213-216.
29. Thomas-Schoemann A., Batteux F., Mongaret C., Nicco C., Chéreau C., Annereau M., et al. Arsenic trioxide exerts antitumor activity through regulatory T cell depletion mediated by oxidative stress in a murine model of colon cancer. J. Immunol 2012, 189(11):5171-5177.
30. Cullen W.R. Chemical mechanism of arsenic biomethylation. Chem. Res. Toxicol 2014, 27(4):457-461.
31. Niedzwiecki M.M., Hall M.N., Liu X., Slavkovich V., Ilievski V., Levy D., et al. Interaction of plasma glutathione redox and folate deficiency on arsenic methylation capacity in Bangladeshi adults. Free Radic. Biol. Med 2014, pii: S0891-5849(14)00160-9.
32. Brocato J., Costa M. Basic mechanics of DNA methylation and the unique landscape of the DNA methylome in metal-induced carcinogenesis. Crit. Rev. Toxicol 2013, 43(6):493-514.
33. Hall M.N., Niedzwiecki M., Liu X., Harper K.N., Alam S., Slavkovich V., et al. Chronic arsenic exposure and blood glutathione and glutathione disulfide concentrations in Bangladeshi adults. Environ. Health Perspect 2013, 121(9):1068-1074.
34. Liu S.X., Davidson M.M., Tang X., Walker W.F., Athar M., Ivanov V., et al. Mitochondrial damage mediates genotoxicity of arsenic in mammalian cells. Cancer Res 2005, 65(8):3236-3242.
35. Liu S.X., Athar M., Lippai I., Waldren C., Hei T.K. Induction of oxyradicals by arsenic: implication for mechanism of genotoxicity. Proc. Natl Acad. Sci. U.S.A. 2001, 98(4):1643-1648.
36. Niedzwiecki M.M., Hall M.N., Liu X., Oka J., Harper K.N., Slavkovich V., et al. A dose-response study of arsenic exposure and global methylation of peripheral blood mononuclear cell DNA in Bangladeshi adults. Environ. Health Perspect 2013, 121(11-12):1306-1312.
37. Hughes M.F., Beck B.D., Chen Y., Lewis A.S., Thomas D.J. Arsenic exposure and toxicology: a historical perspective. Toxicol. Sci 2011, 123(2):305-332.
38. Ushio-Fukai M., Zafari A.M., Fukui T., Ishizaka N., Griendling K.K. p22phox is a critical component of the superoxide-generating NADH/NADPH oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells. J. Biol. Chem 1996, 271(38):23317-23321.
39. Lynn S., Gurr J.R., Lai H.T., Jan K.Y. NADH oxidase activation is involved in arsenite-induced oxidative DNA damage in human vascular smooth muscle cells. Circ. Res 2000, 86(5):514-519.
40. Di-Poï N., Fauré J., Grizot S., Molnár G., Pick E., Dagher M.C. Mechanism of NADPH oxidase activation by the Rac/Rho-GDI complex. Biochemistry 2001, 40(34):10014-10022.
41. Zhang Y.H., Casadei B. Sub-cellular targeting of constitutive NOS in health and disease. J. Mol. Cell. Cardiol 2012, 52(2):341-350. Epub 2011 Sep 16. 10.1016/j.yjmcc.2011.09.006.
42. Mudau M., Genis A., Lochner A., Strijdom H. Endothelial dysfunction: the early predictor of atherosclerosis. Cardiovasc. J. Afr 2012, 23(4):222-231.
43. Kumagai Y. Fusion of field and laboratory studies on the investigation of arsenic. Yakugaku Zasshi 2009, 129(10):1177-1185.
44. Loomis E.D., Sullivan J.C., Osmond D.A., Pollock D.M., Pollock J.S. Endothelin mediates superoxide production and vasoconstriction through activation of NADPH oxidase and uncoupled nitric-oxide synthase in the rat aorta. J. Pharmacol. Exp. Ther 2005, 315(3):1058-1064. Epub 2005 Sep 6.
45. Li L., Watts S.W., Banes A.K., Galligan J.J., Fink G.D., Chen A.F. NADPH oxidase-derived superoxide augments endothelin-1-induced venoconstriction in mineralocorticoid hypertension. Hypertension 2003, 42(3):316-321.
46. Hossain E., Islam K., Yeasmin F., Karim M.R., Rahman M., Agarwal S., et al. Elevated levels of plasma Big endothelin-1 and its relation to hypertension and skin lesions in individuals exposed to arsenic. Toxicol. Appl. Pharmacol 2012, 259(2):187-194.
47. Rahman A., Vahter M., Ekstrom E.C., Persson L.A. Arsenic exposure in pregnancy increases the risk of lower respiratory tract infection and diarrhea during infancy in Bangladesh. Environ. Health Perspect 2011, 119:719-724.
48. Raqib R., Ahmed S., Sultana R., Wagatsuma Y., Mondal D., Hoque A.M., et al. Effects of in utero arsenic exposure on child immunity and morbidity in rural Bangladesh. Toxicol. Lett 2009, 185:197-202.
49. Srivastava R.K., Li C., Chaudhary S.C., Ballestas M.E., Elmets C.A., Robbins D.J., et al. Unfolded protein response (UPR) signaling regulates arsenic trioxide-mediated macrophage innate immune function disruption. Toxicol. Appl. Pharmacol 2013, 272(3):879-887.
50. Nouri K., Ricotti C.A., Bouzari N., Chen H., Ahn E., Bach A. The incidence of recurrent herpes simplex and herpes zoster infection during treatment with arsenic trioxide. J. Drugs Dermatol 2006, 5:182-185.
51. Grivennikov S.I., Greten F.R., Karin M. Immunity, inflammation, and cancer. Cell 2010, 140:883-899.
52. Moreno J.A., Halliday M., Molloy C., Radford H., Verity N., Axten J.M., et al. Oral treatment targeting the unfolded protein response prevents neurodegeneration and clinical disease in prion-infected mice. Sci. Transl. Med 2013, 5(206):206ra138.
53. Walter P., Ron D. The unfolded protein response: from stress pathway to homeostatic regulation. Science 2011, 334(6059):1081-1086. 10.1126/science.1209038.
54. Wheeler D.L., Iida M., Dunn E.F. The role of Src in solid tumors. Oncologist 2009, 14(7):667-678. PMC 3303596. PMID 19581523. 10.1634/theoncologist.2009-0009.
55. Pion M., Stalder R., Correa R., Mangeat B., Towers G.J., Piguet V. Identification of an arsenic-sensitive block to primate lentiviral infection of human dendritic cells. J. Virol 2007, 81:12086-12090.
56. Nayak A.S., Lage C.R., Kim C.H. Effects of low concentrations of arsenic on the innate immune system of the zebrafish (Danio rerio). Toxicol. Sci 2007, 98:118-124.
57. Liao W.T., Yu C.L., Lan C.C., Lee C.H., Chang C.H., Chang L.W., et al. Differential effects of arsenic on cutaneous and systemic immunity: focusing on CD4+ cell apoptosis in patients with arsenic-induced Bowen's disease. Carcinogenesis 2009, 30(6):1064-1072.
58. Mahata J., Basu A., Ghoshal S., Sarkar J.N., Roy A.K., Poddar G., et al. Chromosomal aberrations and sister chromatid exchanges in individuals exposed to arsenic through drinking water in West Bengal, India. Mutat. Res 2003, 534(1-2):133-143.
59. Pei Q., Ma N., Zhang J., Xu W., Li Y., Ma Z., et al. Oxidative DNA damage of peripheral blood polymorphonuclear leukocytes, selectively induced by chronic arsenic exposure, is associated with extent of arsenic-related skin lesions. Toxicol. Appl. Pharmacol 2013, 266(1):143-149. Epub 2012 Nov 8. 10.1016/j.taap.2012.10.031.
60. Hossain M.B., Vahter M., Concha G., Broberg K. Environmental arsenic exposure and DNA methylation of the tumor suppressor gene p16 and the DNA repair gene MLH1: effect of arsenic metabolism and genotype. Metallomics 2012, 4(11):1167-1175.
61. Vahidnia A., van der Voet G.B., de Wolff F.A. Arsenic neurotoxicity - a review. Hum. Exp. Toxicol 2007, 26(10):823-832.
62. Paul S., Banerjee N., Chatterjee A., Sau T.J., Das J.K., Mishra P.K., et al. Arsenic-induced promoter hypomethylation and over-expression of ERCC2 reduces DNA repair capacity in humans by non-disjunction of the ERCC2-Cdk7 complex. Metallomics 2014, Epub ahead of print.
63. Bhattacharjee P., Banerjee M., Giri A.K. Role of genomic instability in arsenic-induced carcinogenicity. A review. Environ. Int 2013, 53:29-40.
64. Roy M., Sinha D., Mukherjee S., Biswas J. Curcumin prevents DNA damage and enhances the repair potential in a chronically arsenic-exposed human population in West Bengal, India. Eur. J. Cancer Prev 2011, 20(2):123-131.
65. Argos M., Parvez F., Chen Y., Hussain A.Z., Momotaj H., Howe G.R., et al. Socioeconomic status and risk for arsenic-related skin lesions in Bangladesh. Am. J. Public Health 2007, 97(5):825-831.
66. Abernathy C.O., Liu Y.P., Longfellow D., Aposhian H.V., Beck B., Fowler B., et al. Arsenic: health effects, mechanisms of actions, and research issues. Environ. Health Perspect 1999, 107:593-597.
67. Li C., Srivastava R.K., Elmets C.A., Afaq F., Athar M. Arsenic-induced cutaneous hyperplastic lesions are associated with the dysregulation of Yap, a Hippo signaling-related protein. Biochem. Biophys. Res. Commun 2013, 438(4):607-612.
68. Gilmore T.D. Introduction to NF-κB: players, pathways, perspectives. Oncogene 2006, 51:6680-6684.
69. Zhao B., Ye X., Yu J., Li L., Li W., Li S., et al. TEAD mediates YAP-dependent gene induction and growth control. Genes Dev 2008, 22(14):1962-1971.
70. Halder G., Johnson R.L. Hippo signaling: growth control and beyond. Development 2011, 138(1):9-22.
71. Fei D.L., Li H., Kozul C.D., Black K.E., Singh S., Gosse J.A., et al. Activation of Hedgehog signaling by the environmental toxicant arsenic may contribute to the etiology of arsenic-induced tumors. Cancer Res 2010, 70(5):1981-1988.
72. Mathas S., Lietz A., Janz M., Hinz M., Jundt F., et al. Inhibition of NF- kappaB essentially contributes to arsenic-induced apoptosis. Blood 2003, 102:1028-1034.
73. Felix K., Manna S.K., Wise K., Barr J., Ramesh G.T. Low levels of arsenite activates nuclear factor-kappaB and activator protein-1 in immortalized mesencephalic cells. J. Biochem. Mol. Toxicol 2005, 19:67-77.
74. Hu Y., Jin X., Snow E.T. Effect of arsenic on transcription factor AP-1 and NF-kappaB DNA binding activity and related gene expression. Toxicol. Lett 2002, 133:33-45.
75. Wijeweera J.B., Gandolfi A.J., Parrish A., Lantz R.C. Sodium arsenite enhances AP-1 and NFkappaB DNA binding and induces stress protein expression in precision-cut rat lung slices. Toxicol. Sci 2001, 61:283-294.
76. Tyler L.N., Ai L., Zuo C., Fan C.Y., Smoller B.R. Analysis of promoter hypermethylation of death-associated protein kinase and p16 tumor suppressor genes in actinic keratoses and squamous cell carcinomas of the skin. Mod. Pathol 2003, 16(660-664).
77. Trouba K.J., Wauson E.M., Vorce R.L. Sodium arsenite-induced dysregulation of proteins involved in proliferative signaling. Toxicol. Appl. Pharmacol 2000, 164(2):161-170.
78. Sharma M., Sharma S., Arora M., Kaul D. Regulation of cellular Cyclin D1 gene by arsenic is mediated through miR-2909. Gene 2013, 522(1):60-64.
79. Sun J., Yu M., Lu Y., Thakur C., Chen B., Qiu P., et al. Carcinogenic metalloid arsenic induces expression of mdig oncogene through JNK and STAT3 activation. Cancer Lett 2014, pii: S0304-3835(14)00016-0.
80. Lu Y., Chang Q., Zhang Y., Beezhold K., Rojanasakul Y., Zhao H., et al. Lung cancer-associated JmjC domain protein mdig suppresses formation of tri-methyl lysine 9 of histone H3. Cell Cycle 2009, 8(13):2101-2109.
81. Wang Z., Yang J., Fisher T., Xiao H., Jiang Y., Yang C. Akt activation is responsible for enhanced migratory and invasive behavior of arsenic-transformed human bronchial epithelial cells. Environ. Health Perspect 2012, 120(1):92-97.
82. Wang Z., Humphries B., Xiao H., Jiang Y., Yang C. Epithelial to mesenchymal transition in arsenic-transformed cells promotes angiogenesis through activating β-catenin-vascular endothelial growth factor pathway. Toxicol. Appl. Pharmacol 2013, 271(1):20-29.
83. Ameyar M., Wisniewska M., Weitzman J.B. A role for AP-1 in apoptosis: the case for and against. Biochimie 2003, 85(8):747-752.
84. Hossain E., Ota A., Takahashi M., Karnan S., Damdindorj L., Konishi Y., et al. Arsenic upregulates the expression of angiotensin II type I receptor in mouse aortic endothelial cells. Toxicol. Lett 2013, 220(1):70-75.
85. Waalkes M.P., Ward J.M., Diwan B.A. Induction of tumors of the liver, lung, ovary and adrenal in adult mice after brief maternal gestational exposure to inorganic arsenic: promotional effects of postnatal phorbol ester exposure on hepatic and pulmonary, but not dermal cancers. Carcinogenesis 2004, 25(1):133-141.
86. Burns F.J., Uddin A.N., Wu F., Nádas A., Rossman T.G. Arsenic-induced enhancement of ultraviolet radiation carcinogenesis in mouse skin: a dose-response study. Environ. Health Perspect 2004, 112:599-603.
87. Chen Y., Megosh L.C., Gilmour S.K., Sawicki J.A., O'Brien T.G. K6/ODC trans-genic mice as a sensitive model for carcinogen identification. Toxicol. Lett 2000, 116:27-35.
88. Morikawa T., Wanibuchi H., Morimura K., Ogawa M., Fukushima S. Promotion of skin carcinogenesis by dimethylarsinic acid in keratin (K6)/ ODC transgenic mice. Jpn J. Cancer Res 2000, 91:579-581.
89. Rossman T.G., Uddin A.N., Burns F.J., Bosland M.C. Arsenite is a cocarcino-gen with solar ultraviolet radiation for mouse skin: an animal model for arsenic carcinogenesis. Toxicol. Appl. Pharmacol 2001, 176:64-71.
90. Uddin A.N., Burns F.J., Rossman T.G. Vitamin E and organoselenium pre- vent the cocarcinogenic activity of arsenite with solar UVR in mouse skin. Carcinogenesis 2005, 26:2179-2186.
91. Tokar E.J., Benbrahim-Tallaa L., Ward J.M., Lunn R., Sams R.L., Waalkes M.P. Cancer in experimental animals exposed to arsenic and arsenic compounds. Crit. Rev. Toxicol 2010, 40(10):912-927.
92. Sun Y., Kojima C., Chignell C., Mason R., Waalkes M.P. Arsenic transformation predisposes human skin keratinocytes to UV-induced DNA damage yet enhances their survival apparently by diminishing oxidant response. Toxicol. Appl. Pharmacol 2011, 255(3):242-250.
93. Zuo Z., Ouyang W., Li J., Costa M., Huang C. Cyclooxygenase-2 (COX-2) mediates arsenite inhibition of UVB-induced cellular apoptosis in mouse epidermal Cl41 cells. Curr. Cancer Drug Targets 2012, 12(6):607-616.
94. Gilbert-Diamond D., Li Z., Perry A.E., Spencer S.K., Gandolfi A.J., Karagas M.R. A population-based case-control study of urinary arsenic species and squamous cell carcinoma in New Hampshire, USA. Environ. Health Perspect 2013, 121(10):1154-1160.
95. Cottingham K.L., Karimi R., Gruber J.F., Zens M.S., Sayarath V., Folt C.L., et al. Diet and toenail arsenic concentrations in a New Hampshire population with arsenic-containing water. Nutr. J. 2013, 12:149. 10.1186/1475-2891-12-149.
96. Gruber J.F., Karagas M.R., Gilbert-Diamond D., Bagley P.J., Zens M.S., Sayarath V., et al. Associations between toenail arsenic concentration and dietary factors in a New Hampshire population. Nutr. J. 2012, 11:45.